Shares of Evoke plc (LON:EVOK – Get Free Report) were up 14.5% on Thursday . The stock traded as high as GBX 48.90 ($0.64) and last traded at GBX 48.90 ($0.64). Approximately 42,064,105 shares traded hands during trading, an increase of 1,236% from the average daily volume of 3,148,381 shares. The stock had previously closed at GBX 42.70 ($0.56).
Analysts Set New Price Targets
Separately, Jefferies Financial Group restated a “buy” rating and issued a GBX 140 ($1.83) price objective on shares of Evoke in a research report on Monday, December 16th.
View Our Latest Stock Analysis on EVOK
Evoke Stock Performance
Evoke (LON:EVOK – Get Free Report) last posted its quarterly earnings data on Wednesday, March 26th. The company reported GBX (6.40) (($0.08)) EPS for the quarter. Evoke had a negative net margin of 8.50% and a negative return on equity of 517.98%. On average, equities research analysts expect that Evoke plc will post 12.7648305 earnings per share for the current fiscal year.
Insiders Place Their Bets
In other Evoke news, insider Andrea Gisle Joosen acquired 14,572 shares of the stock in a transaction that occurred on Tuesday, January 28th. The stock was bought at an average cost of GBX 70 ($0.92) per share, for a total transaction of £10,200.40 ($13,351.31). Also, insider Jonathan (Jon) Mendelsohn acquired 200,000 shares of Evoke stock in a transaction that occurred on Monday, March 31st. The stock was bought at an average price of GBX 48 ($0.63) per share, for a total transaction of £96,000 ($125,654.45). 27.00% of the stock is currently owned by corporate insiders.
About Evoke
Featured Stories
- Five stocks we like better than Evoke
- What is a penny stock? A comprehensive guide
- Robinhood Strategies Could Be a Game-Changer for Young Investors
- What to Know About Investing in Penny Stocks
- Are These 3 Retail Stocks Oversold or Really in Trouble?
- The 3 Best Blue-Chip Stocks to Buy Now
- IONQ & RGTI Join DARPA Quantum Initiative: High Stakes Are Ahead
Receive News & Ratings for Evoke Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Evoke and related companies with MarketBeat.com's FREE daily email newsletter.